AAAAAA

   
Results: 1-20 |
Results: 20
IMPACT OF ENDOGENOUS THROMBOPOIETIN LEVELS ON THE DIFFERENTIAL-DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA AND REACTIVE THROMBOCYTOSIS
Authors: HOU M CARNESKOG J MELLQVIST UH STOCKELBERG D HEDBERG M WADENVIK H KUTTI J
Citation: M. Hou et al., IMPACT OF ENDOGENOUS THROMBOPOIETIN LEVELS ON THE DIFFERENTIAL-DIAGNOSIS OF ESSENTIAL THROMBOCYTHEMIA AND REACTIVE THROMBOCYTOSIS, European journal of haematology, 61(2), 1998, pp. 119-122
PLASMA ERYTHROPOIETIN BY HIGH-DETECTABILITY IMMUNORADIOMETRIC ASSAY IN UNTREATED AND TREATED PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA
Authors: CARNESKOG J KUTTI J WADENVIK H LUNDBERG PA LINDSTEDT G
Citation: J. Carneskog et al., PLASMA ERYTHROPOIETIN BY HIGH-DETECTABILITY IMMUNORADIOMETRIC ASSAY IN UNTREATED AND TREATED PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA, European journal of haematology, 60(5), 1998, pp. 278-282
CYCLOPHENILE IN 9 CASES OF SEVERE SCLEROTIC CH GVHD OF THE SKIN
Authors: LONNQVIST B CARNESKOG J
Citation: B. Lonnqvist et J. Carneskog, CYCLOPHENILE IN 9 CASES OF SEVERE SCLEROTIC CH GVHD OF THE SKIN, Bone marrow transplantation, 21, 1998, pp. 387-387
TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS
Authors: HELLSTROMLINDBERG E AHLGREN T BEGUIN Y CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G KANTERLEWENSOHN L LINDER O LUTHMAN M LOFVENBERG E NILSSONEHLE H SAMUELSSON J TANGEN JM WINQVIST I OBERG G OSTERBORG A OST A
Citation: E. Hellstromlindberg et al., TREATMENT OF ANEMIA IN MYELODYSPLASTIC SYNDROMES WITH GRANULOCYTE-COLONY-STIMULATING FACTOR PLUS ERYTHROPOIETIN - RESULTS FROM A RANDOMIZEDPHASE-II STUDY AND LONG-TERM FOLLOW-UP OF 71 PATIENTS, Blood, 92(1), 1998, pp. 68-75
HISTAMINE AND INTERLEUKIN-2 IN ACUTE MYELOGENOUS LEUKEMIA
Authors: HELLSTRAND K MELLQVIST UH WALLHULT E CARNESKOG J KIMBY E CELSING F BRUNE M
Citation: K. Hellstrand et al., HISTAMINE AND INTERLEUKIN-2 IN ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 27(5-6), 1997, pp. 429-438
HISTAMINE IN CANCER-IMMUNOTHERAPY
Authors: HELLSTRAND K HERMODSSON S BRUNE M NAREDI P CARNESKOG J MELLQVIST UH
Citation: K. Hellstrand et al., HISTAMINE IN CANCER-IMMUNOTHERAPY, Scandinavian journal of clinical & laboratory investigation, 57(3), 1997, pp. 193-202
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G LINDER O BJORKHOLM M CARNESKOG J STENKE L KARLE H LANNGNIELSEN J LOFVENBERG E MALM C PAUL C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Blood, 90(10), 1997, pp. 1744-1744
OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT
Authors: JOHNSEN HE BJORKSTRAND B CARLSON K GRUBER A BLYSTAD A FAST A BOESEN AM BJORKHOLM M SALLERFORS B RUUTU T CARNESKOG J MALM A GEISLER C LEHTINEN M SCHRODER H BRINCH L REMES K TIDEFELT U HEILMANN C HORNSTEN P THORLING K DAUGAARD G
Citation: He. Johnsen et al., OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT, Leukemia & lymphoma, 24(1-2), 1996, pp. 81-91
FLOW CYTOMETRIC ANALYSIS OF MEGAKARYOCYTE PLOIDY IN CHRONIC MYELOPROLIFERATIVE DISORDERS AND REACTIVE THROMBOCYTOSIS
Authors: JACOBSSON S CARNESKOG J RIDELL B WADENVIK H SWOLIN B KUTTI J
Citation: S. Jacobsson et al., FLOW CYTOMETRIC ANALYSIS OF MEGAKARYOCYTE PLOIDY IN CHRONIC MYELOPROLIFERATIVE DISORDERS AND REACTIVE THROMBOCYTOSIS, European journal of haematology, 56(5), 1996, pp. 287-292
ASSESSMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN NEWLY-DIAGNOSED PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA-VERA
Authors: CARNESKOG J WADENVIK H FJALLING M KUTTI J
Citation: J. Carneskog et al., ASSESSMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN NEWLY-DIAGNOSED PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA-VERA, European journal of haematology, 56(3), 1996, pp. 158-162
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML
Authors: SIMONSSON B OBERG G BJOREMAN M BJORKHOLM M CARNESKOG J GAHRTON G HAST R KARL H LANNGNIELSEN J LOFVENBERG E MALM C TURESSON I UDEN AM VILEN L WEISBJERRUM O
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CML, Bone marrow transplantation, 17, 1996, pp. 63-64
TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY
Authors: HELLSTROMLINDBERG E TANGEN JM GRIMFORS G LINDEMALM C CARLSSON M OBERG G LOWENBERG E LINDER O DYBEDAL I DAHL IM NILSSONEHLE H AHLGREN T WINQUIST I CARNESKOG J LUTHMAN M
Citation: E. Hellstromlindberg et al., TREATMENT OF THE ANEMIA IN MDS WITH G-CSF AND EPO - FINAL REPORT FROMA RANDOMIZED PHASE-II STUDY, Blood, 88(10), 1996, pp. 1805-1805
INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL
Authors: HJORTH M WESTIN J DAHL IMS GIMSING P HIPPE E HOLMBERG E LAMVIK J NIELSEN JL LOFVENBERG E PALVA IP RODJER S TALSTAD I TURESSON I WISLOFF F ZADOR G AMSLERNORDIN S POLGARY M ODEN A WALLGREN A WILHELMSEN L HELLQVIST L HASSELBLOM S CARNESKOG J LINDQVIST O HOFFMAN P OLSSON K THOLEN A STOLT CM RINDNER A SVENSSON R VAART J HANSEN S ENGQVIST L LANNEMYR O NILSSON PG LINNE I LILJA G TALLROTH G HALLGREN J ANDERSSON B BILLSTROM R PERSSON S SAMUELSSON T ODEBERG H ADRIANSSON M TOVE H STOBEUS N HABBERSTAD J END T DAHLEN M ERIKSSON M ANAGRIUS N ARONSON D NEZADAL L ERIKSSON K HEDENUS M RYDE J WESTIN L ANDERSSON LO BJURMAN A FORSBERG K FORS D WIKSTROM S THULE B BOLSOY U LENNERMO K STRAND T PALVA I ALMQVIST A ISOMAA B OKSANEN K EIKA C LY B BRANDT E WEYDE K FOSSUM C LOVASEN K SPARBY JA JACOBSEN EM RINDE M NYHUS S KAHRS J STEEN T GRAVDAHL H BORGE L GROTTUM KA FLOTTEROD O STROM BR KNUTSEN H DRIVENES A PAULSEN J RIIS S HAUGE PW NESTHUS I COLL P HOLE KH SAETER T SINDRE T BERENTSEN S NES H VAGSTAD G HEIKKELA R SHAMMAS V LODEMEL B SKOGEN OR SORUM Y KVAMBE V BULL O JAEGER S INGVALDSEN PG PEDERSEN K HANSEN LT ONKIEHONG M HAUGNES T STEFANSEN D GADEBERG O ABILDGAARD N JANS H MOURITSANDERSEN T NEUBAUER B CLAUSEN NT MAGNUSSON S EYJOLFSSON G BJORNSSON S
Citation: M. Hjorth et al., INTERFERON-ALPHA-2B ADDED TO MELPHALAN-PREDNISONE FOR INITIAL AND MAINTENANCE THERAPY IN MULTIPLE-MYELOMA - A RANDOMIZED, CONTROLLED TRIAL, Annals of internal medicine, 124(2), 1996, pp. 212
EFFECTS OF ERWINIA-ASPARAGINASE ON THE COAGULATION SYSTEM
Authors: CARLSSON H STOCKELBERG D TENGBORN L BRAIDE I CARNESKOG J KUTTI J
Citation: H. Carlsson et al., EFFECTS OF ERWINIA-ASPARAGINASE ON THE COAGULATION SYSTEM, European journal of haematology, 55(5), 1995, pp. 289-293
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML)
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G STENKE L TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA (CML), Bone marrow transplantation, 14, 1994, pp. 55-56
SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION
Authors: HELLSTROMLINDBERG E CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G LINDEMALM C LINDER O LOFVENBERG E NILSSONEHLE H TANGEN JM TURESSON I WINQVIST I OBERG G BEGIN Y OST A
Citation: E. Hellstromlindberg et al., SYNERGISTIC EFFECT OF G-CSF AND EPO ON THE ANEMIA IN PATIENTS WITH MDS - EVIDENCE FOR INCREASED ERYTHROPOIETIC EFFECTIVENESS RATHER THAN EXPANSION, Blood, 84(10), 1994, pp. 10000317-10000317
MEASUREMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN CHRONICMYELOPROLIFERATIVE DISORDERS
Authors: CARNESKOG J WADENVIK H JOHANSSON JE KUTTI J
Citation: J. Carneskog et al., MEASUREMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN CHRONICMYELOPROLIFERATIVE DISORDERS, Blood, 84(10), 1994, pp. 10000630-10000630
INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA
Authors: SIMONSSON B OBERG G KILLANDER A BJOREMAN M BJORKHOLM M GAHRTON G HAST R TURESSON I UDEN AM MALM C VILEN L WAHLIN A LOFVENBERG E CARNESKOG J WESTIN J
Citation: B. Simonsson et al., INTENSIVE TREATMENT IN ORDER TO MINIMIZE THE PH-POSITIVE CLONE IN CHRONIC MYELOGENIC LEUKEMIA, Stem cells, 11, 1993, pp. 73-76
A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: HELLSTROMLINDBERG E BIRGEGARD G CARLSSON M CARNESKOG J DAHL IM DYBEDAL I GRIMFORS G MERK K TANGEN JM WINQVIST I OST A
Citation: E. Hellstromlindberg et al., A COMBINATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR AND ERYTHROPOIETIN MAY SYNERGISTICALLY IMPROVE THE ANEMIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 11(3-4), 1993, pp. 221-228
MEASUREMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN ESSENTIAL THROMBOCYTHEMIA
Authors: REVESZ P CARNESKOG J WADENVIK H JARNEBORN L KUTTI J
Citation: P. Revesz et al., MEASUREMENT OF SPLEEN SIZE USING GAMMA-CAMERA SCINTIGRAPHY IN ESSENTIAL THROMBOCYTHEMIA, European journal of haematology, 51(3), 1993, pp. 141-143
Risultati: 1-20 |